Advanced search
Publication Cover
Expert Review of Hematology Volume 11, 2018 - Issue 1
Submit an article Journal homepage
118
Views
16
CrossRef citations to date
0
Altmetric
Special Report

The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts

Jae Youn MoonDivision of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USAView further author information
,
Francesco FranchiDivision of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USAView further author information
,
Fabiana RolliniDivision of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USAView further author information
&
Dominick J. AngiolilloDivision of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USACorrespondence[email protected]
View further author information
Pages 5-12 | Received 01 Sep 2017, Accepted 31 Oct 2017, Published online: 14 Nov 2017

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mattia Galli, Davide Capodanno, Felicita Andreotti, Filippo Crea & Dominick J Angiolillo. (2021) Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions. Expert Opinion on Drug Safety 20:1, pages 9-21.
Read now
Sergio Buccheri, Davide Capodanno, Stefan James & Dominick J. Angiolillo. (2019) Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms. Expert Opinion on Drug Safety 18:12, pages 1171-1189.
Read now

Articles from other publishers (14)

Zheng Cao, Jun Li, Zhao Fang, Yushanjiang Feierkaiti, Xiaoxin Zheng & Xuejun Jiang. (2022) The factors influencing the efficiency of drug-coated balloons. Frontiers in Cardiovascular Medicine 9.
Crossref
Matteo Bianco, Alessandro Careggio, Paola Destefanis, Alessia Luciano, Maria Giulia Perrelli, Giorgio Quadri, Roberta Rossini, Gianluca Campo, Giampiero Vizzari, Fabrizio D’Ascenzo, Matteo Anselmino, Giuseppe Biondi-Zoccai, Borja Ibáñez, Laura Montagna, Ferdinando Varbella & Enrico Cerrato. (2021) P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients. European Heart Journal - Cardiovascular Pharmacotherapy 7:3, pages 196-205.
Crossref
Charles V. PollackJr.Jr. & Tracy Y. Wang. (2021) Evolution of Clinical Thinking and Practice Regarding Aspirin: What Has Changed and Why?. The American Journal of Cardiology 144, pages S10-S14.
Crossref
Davide Capodanno, Marie-Claude Morice, Dominick J. Angiolillo, Deepak L. Bhatt, Robert A. Byrne, Roisin Colleran, Thomas Cuisset, Donald Cutlip, Pedro Eerdmans, John Eikelboom, Andrew Farb, C. Michael Gibson, John Gregson, Michael Haude, Stefan K. James, Hyo-Soo Kim, Takeshi Kimura, Akihide Konishi, Martin B. Leon, P.F. Adrian Magee, Yoshiaki Mitsutake, Darren Mylotte, Stuart J. Pocock, Sunil V. Rao, Ernest Spitzer, Norman Stockbridge, Marco Valgimigli, Olivier Varenne, Ute Windhovel, Mitchel W. Krucoff, Philip Urban & Roxana Mehran. (2020) Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI. Journal of the American College of Cardiology 76:12, pages 1468-1483.
Crossref
Antonio Greco & Davide Capodanno. (2020) Long-term monotherapy with ticagrelor after coronary stenting: the GLOBAL LEADERS study. European Heart Journal Supplements 22:Supplement_E, pages E46-E49.
Crossref
Nasser Saadat, Seyedmohammad Saadatagah, Arash Aghajani Nargesi, Mohammad Alidoosti, Hamidreza Poorhosseini, Alireza Amirzadegan, Reza Lashkari, Seyedeh Hamideh Mortazavi, Arash Jalali, Saeed Ghodsi & Mojtaba Salarifar. (2019) Short‐term safety and long‐term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study. Catheterization and Cardiovascular Interventions 95:7, pages 1249-1256.
Crossref
Dominick J. Angiolillo. (2020) Editorial commentary: Evolving paradigms in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention. Trends in Cardiovascular Medicine 30:4, pages 203-204.
Crossref
S. G. Kanorskii. (2020) Combined Antithrombotic Therapy in Patients with a Stable Atherosclerotic Cardiovascular Diseases: What Direction did COMPASS Show?. Kardiologiia 60:2, pages 131-141.
Crossref
Sung Won Cho, Francesco Franchi & Dominick J. Angiolillo. (2019) Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations. Therapeutic Advances in Hematology 10, pages 204062071986147.
Crossref
Sergio Buccheri, Dominick J. Angiolillo & Davide Capodanno. (2019) Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting. Therapeutic Advances in Cardiovascular Disease 13, pages 175394471989168.
Crossref
Davide Capodanno, Fernando Alfonso, Glenn N. Levine, Marco Valgimigli & Dominick J. Angiolillo. (2018) ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy. Journal of the American College of Cardiology 72:23, pages 2915-2931.
Crossref
Yingqiu Liu, Tianyi Liu, Kevin Ding, Zengyuan Liu, Yuanyuan Li, Taotao He, Weimin Zhang, Yunpeng Fan, Wuren Ma, Li Cui & Xiaoping Song. (2018) Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc. Frontiers in Pharmacology 9.
Crossref
Davide Capodanno, Roxana Mehran, Marco Valgimigli, Usman Baber, Stephan Windecker, Pascal Vranckx, George Dangas, Fabiana Rollini, Takeshi Kimura, Jean-Philippe Collet, C. Michael Gibson, Philippe Gabriel Steg, Renato D. Lopes, Hyeon-Cheol Gwon, Robert F. Storey, Francesco Franchi, Deepak L. Bhatt, Patrick W. Serruys & Dominick J. Angiolillo. (2018) Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nature Reviews Cardiology 15:8, pages 480-496.
Crossref
Jae Youn Moon, Francesco Franchi, Fabiana Rollini & Dominick J. Angiolillo. (2018) Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy. Progress in Cardiovascular Diseases 60:4-5, pages 478-490.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.